Other Useful Information > Letters to Trade

Letters to Trade   FDA Approves Labeling Changes for Over-the-Counter (OTC) Weight Loss Drug alli (Orlistat) to Warn of Risk of Kidney Stones and Kidney Injury (Letter to Healthcare Professionals)       Attachment: Orlistat   Related Information: The United States: FDA approves labeling changes for Over-the-Counter (OTC) weig... Posted 2026-06-11 China State Food and Drug Administration: Label changes of Orlistat (Letter to H... Posted 2012-05-08 China: SFDA updates Orlistat label Posted 2012-05-08